SCHEMBL9622210

SCHEMBL9622210

COc1ccc(CSC2CCNCC2)c(OC)c1OC

nearest known ligand 0.52

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.52
CHRM2 P08172 1/20 0.52
SLC6A4 P31645 1/20 0.52
OPRD1 P41143 1/20 0.52
OPRK1 P41145 1/20 0.52
APOBEC3A P31941 1/20 0.51
CTDSP1 Q9GZU7 1/20 0.51
APOBEC3G Q9HC16 1/20 0.51
AOC3 Q16853 1/20 0.39
PARP14 Q460N5 1/20 0.39
HTR2C P28335 2/20 0.38
QRFPR Q96P65 9/20 0.37
POLB P06746 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GNAI3 P08754 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9622848 0.82 CHRM2 (0.45) CYP1A2CHRM2SLC6A4OPRD1OPRK1
SCHEMBL27549083 0.78 SLC6A4 (0.56) CYP1A2CHRM2SLC6A4OPRD1OPRK1
SCHEMBL9622896 0.74 ALDH1A1 (0.46) POLBSMN1; SMN2MEN1KMT2A
SCHEMBL9367286 0.71 SMN1; SMN2 (0.48) CYP1A2HTR2CSMN1; SMN2MEN1KMT2A
SCHEMBL9367280 0.71 SMN1; SMN2 (0.48) CYP1A2HTR2CSMN1; SMN2MEN1KMT2A
SCHEMBL8307284 0.70 TDP1 (0.50) SMN1; SMN2MEN1KMT2A
SCHEMBL9622597 0.69 LMNA (0.44) CHRM2SLC6A4OPRK1HTR2CSMN1; SMN2
Trimetazidine SCHEMBL29375563 0.69 CHRM2 (1.00) CYP1A2CHRM2SLC6A4OPRD1OPRK1
Trimetazidine SCHEMBL230374 0.69 CHRM2 (1.00) CYP1A2CHRM2SLC6A4OPRD1OPRK1
Trimetazidine SCHEMBL11846840 0.69 CHRM2 (1.00) CYP1A2CHRM2SLC6A4OPRD1OPRK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5126356-A Antiischemic agents ADIR ET COMPAGNIE (FR) 1992-06-30 US disclosed